Klein M R, Smith S M, Hammond A S, Ogg G S, King A S, Vekemans J, Jaye A, Lukey P T, McAdam K P
Tuberculosis Research Programme, Medical Research Council Laboratories, Fajara, BANJUL, Gambia, West Africa.
J Infect Dis. 2001 Mar 15;183(6):928-34. doi: 10.1086/319267. Epub 2001 Feb 21.
Few target epitopes have been described for human CD8 T lymphocytes in antigens of Mycobacterium tuberculosis. By use of a reverse immunogenetics approach, 23 motif-bearing peptides of the Ag85 complex were tested for binding to HLA-B35, one of the common B-types in West Africa. Three 9-mer peptides bound with high affinity to HLA-B3501 and displayed low dissociation rates of peptide-major histocompatibility complexes (MHCs). IC(50) and half-life values of peptide-MHC class I complexes were in the same range as reported earlier for other immunogenic peptides. Immune responses against peptide Ag85C (aa 204-212) WPTLIGLAM were characterized in detail. Peptide-stimulated effector cells were able to kill macrophages infected with M. tuberculosis or bacille Calmette-Guérin. Peptide-specific CD8 T cells could be visualized by using HLA-B*3501 tetramers and were shown to produce interferon-gamma and tumor necrosis factor-alpha. Together with other published epitopes, these peptides can be used to study more closely the role of CD8 T cells in mycobacterial infection and tuberculosis.
在结核分枝杆菌抗原中,针对人类CD8 T淋巴细胞的靶表位鲜有报道。通过使用反向免疫遗传学方法,对Ag85复合物的23个含基序肽段进行了与HLA - B35(西非常见的B型之一)结合的测试。三个9聚体肽段与HLA - B3501具有高亲和力结合,且肽 - 主要组织相容性复合体(MHC)的解离率较低。肽 - MHC I类复合体的IC(50)和半衰期值与先前报道的其他免疫原性肽段处于同一范围。对针对肽段Ag85C(氨基酸204 - 212)WPTLIGLAM的免疫反应进行了详细表征。肽段刺激的效应细胞能够杀伤感染结核分枝杆菌或卡介苗的巨噬细胞。肽特异性CD8 T细胞可通过使用HLA - B*3501四聚体进行可视化,并显示可产生γ干扰素和肿瘤坏死因子 - α。连同其他已发表的表位,这些肽段可用于更深入地研究CD8 T细胞在分枝杆菌感染和结核病中的作用。